GLP-1 (7-36)-Lys(biotinyl) amide (human, bovine, guinea pig, mouse, rat)

GLP-1 (7-36)-Lys(biotinyl) amide (human, bovine, guinea pig, mouse, rat)

GLP-1 (7-36)-Lys(biotinyl) amide (human, bovine, guinea pig, mouse, rat)

GLP-1 (7-36)-Lys(biotinyl) amide (human, bovine, guinea pig, mouse, rat)

GLP-1 (7-36)-Lys(biotinyl) amide (human, bovine, guinea pig, mouse, rat)

GLP-1 (7-36)-Lys(biotinyl) amide is a universal biotinylated research reagent that includes the major active form of Glucagon-Like Peptide 1 (the 7-36 fragment) with a C-terminal lysine residue conjugated to biotin. This product is offered as a species-crossreactive conjugate, featuring sequences compatible with human, bovine, guinea pig, mouse, and rat GLP-1 receptors due to high sequence homology in this region. 



TECHNICAL SPECIFICATIONS


Item
Specification
Product Name
GLP-1 (7-36)-Lys(biotinyl) amide (human, bovine, guinea pig, mouse, rat)
CAS NO.
/
Appearance
White to off-white lyophilized powder
Molecular Formula
C165H252N44O48S
Molecular Weight
3652.18g/mol 
Purity (RP-HPLC)
≥ 95.0%
Solubility

Soluble in water (≥ 5 mg/mL), dilute acetic acid, or DMSO; also soluble in phosphate-buffered saline (PBS)

Endotoxin≤1.0 EU/mg
Biological Activity
 Retains native GLP-1 receptor agonist activity; EC₅₀ typically ≤ 0.3 nM in cAMP accumulation assays; biotin label enables detection via streptavidin conjugates
Storage Conditions
Store at -20°C to -80°C in a dry, dark, desiccated environment.
Stock Location
Stock in USA
MOQ
1g


1.MECHANISM OF ACTION

This biotinylated conjugate functions as a high-affinity, full agonist for the GLP-1 Receptor (GLP-1R) across multiple species. It binds specifically to the extracellular domain of GLP-1R, a Class B G-protein coupled receptor, and activates canonical downstream signaling. Receptor engagement stimulates Gs-protein coupling, activating adenylate cyclase and elevating intracellular cyclic AMP (cAMP). This triggers protein kinase A (PKA) and Epac2 pathways, leading to glucose-dependent insulin secretion in beta cells, suppression of glucagon release, slowed gastric emptying, and enhanced satiety signaling.


    2.PRODUCT INDICATIONS

    Multi-Species Receptor Studies: Ideal for comparative GLP-1R research across human, rodent (mouse, rat, guinea pig), and bovine models using a single, cross-reactive reagent.

    Receptor Visualization & Trafficking: For immunohistochemistry (IHC), immunofluorescence (IF), and live-cell imaging of GLP-1R localization, expression, and internalization using streptavidin-fluorophore conjugates.

    Affinity Purification & Proteomics: Isolating native GLP-1R complexes from tissue lysates or cell lines via streptavidin bead pull-down for mass spectrometry or Western blot analysis.

    Biosensor & Binding Assay Development: Immobilizing the peptide on streptavidin-coated surfaces (SPR chips, ELISA plates, BLI sensors) for kinetic studies, ligand screening, and diagnostic assay development.

    Flow Cytometry: Quantifying cell surface GLP-1R expression on live cells using streptavidin-conjugated fluorochromes.

    High-Throughput Screening (HTS): Serving as a universal tagged ligand in screening campaigns for GLP-1R agonists, antagonists, or allosteric modulators across different species.

     

    3.CLINICAL EFFICACY OF PRODUCT

    Research & Diagnostic Tool Efficacy: Its efficacy is defined by its performance in the laboratory—specifically, its ability to bind GLP-1R with high affinity across species and enable sensitive detection, quantification, and isolation of the receptor in complex biological samples.

    Enabling Translational Research: By facilitating detailed studies of GLP-1R biology in preclinical animal models (mouse, rat, guinea pig) and human systems, this tool contributes to the mechanistic understanding that underpins GLP-1-based therapies.

    Supporting Drug Discovery: It is invaluable in characterizing lead compounds, performing receptor occupancy studies, and validating assay systems during the development of GLP-1R-targeting drugs like semaglutide, liraglutide, and tirzepatide.

    Clinical Correlation: The GLP-1 pathway itself is the target of highly efficacious FDA-approved drugs for type 2 diabetes and obesity. This reagent helps bridge preclinical findings to human biology, but the conjugate itself is not a therapeutic.

     

    4.DELIVERY & SHIPPING

    We specialize in global logistics for various cosmetic peptides. Your order will be handled with the utmost care, ensuring safe, reliable, and intact delivery.
    Professional and Secure Packaging
    Each bottle of peptide is protected with a special packaging solution to ensure stability and integrity during transportation.
    We can also customize packaging according to customer needs.
    Shipping Methods 
    Main Method: International Air Freight

    We primarily use DHL, FedEx, UPS, and TNT because of their global reliability, speed, and advanced tracking systems. Air freight ensures the fastest transit time and minimizes the impact of environmental factors on the product.

Premium API Oxandrolone Ucinky Manufacturing
May 25, 26
Premium API Oxandrolone Ucinky Manufacturing
Premium API Oxandrolone Ucinky Manufacturing Leading global supplier of high-purity chemical raw materials for pharmaceutical grade Oxandrolone Ucinky, combining precision engineering with industrial scale. 5000 kg Annual Output 120 Countries Served 5 Days Sample Lead Time 99.7 On-Time Delivery Industrial Precision Pure Chemical Synthesis Engineering the future of pharmaceutical intermediates with unmatched stability. Our facility stands as a global leader in the oxandrolone ucinky sector, utilizing CRYOGENIC CRYSTALLIZATION and advanced chromatography to ensure an assay purity exceeding 99.8. We integrate a fully automated closed-loop system that eliminates human error and contamination.
Clinical Benefits and Applications of Oxandrolone Therapy
May 22, 26
Clinical Benefits and Applications of Oxandrolone Therapy
Oxandrolone therapy represents a sophisticated intersection of endocrine science and regenerative medicine, primarily utilized to address muscle wasting and metabolic dysfunction. In the global pharmaceutical landscape, this specific approach to androgen therapy is valued for its unique ability to promote protein synthesis while exhibiting a lower androgenic profile compared to traditional steroids, making it a critical tool for patients recovering from severe trauma or chronic illness. From a clinical perspective, understanding the nuances of oxandrolone therapy is essential for optimizing patient outcomes in weight gain and tissue repair.
Clinical Benefits and Production of Oxandrolone Steroid
May 20, 26
Clinical Benefits and Production of Oxandrolone Steroid
The global pharmaceutical landscape has seen a significant rise in the demand for highly specialized anabolic agents, among which the oxandrolone steroid stands out due to its unique chemical profile and therapeutic versatility. As a modified version of dihydrotestosterone, this compound provides a potent means of addressing muscle wasting and metabolic deficits, making it a critical asset in both clinical rehabilitation and advanced physiological research. Understanding the nuances of this synthetic compound is essential for healthcare providers and researchers alike, as it balances efficacy with a relatively lower androgenic profile compared to other steroids.

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.